301093.SZ
Jiangsu Hualan New Pharmaceutical Material Co., Ltd.
SZSE · C 制造业 · CN
CNY 50.92
+6.80%Year over year
Reported trailing growth
- Revenue
- -0.3%
- EBITDA
- —
- EBIT
- -29.1%
- EPS
- -24.1%
- Free cash flow
- +91.4%
- Operating cash flow
- +313.1%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +2.0%
- EBITDA
- +4.4%
- EBIT
- -13.8%
- Net income
- -13.7%
- EPS
- -19.2%
- Free cash flow
- -16.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026